A Swedish court has ruled that a product containing CBD for oral consumption cannot automatically be classified as a pharmaceutical, but that the legal status of each product must be assessed individually
Written by CannIntelligence || 14th October 2019 || News analysis | Regulation and legislation | Europe Sweden